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In this issue of the Biomedical Journal we discover how alternative splicing might modulate
the cell-type specificity and exact function of a ubiquitous purinergic receptor and how the
beta blocker propanolol can contribute to breast cancer therapy. Moreover, we learn which
culture conditions generate the best vascularisation of tissue engineered bone and which
are the clinical features of acute necrotising encephalopathy in adults. Other studies
reveal, how laser irradiation can fix fractured all-ceramic dental restorations in situ, and
finally that nuclear magnetic resonance holds great potential for the rapid detection of
pathogens.Spotlight on review
Puzzling mRNA: alternative splicing fine-tunes specificity
and function
Alternative splicing refers to the process of variable assembly
of one gene's exons giving rise to a multitude of messenger
RNA (mRNA) isoforms and thus different peptides or non-
coding RNAs. This mechanism, present in all eukaryotes,
manifolds the diversity of possible gene products, increases
information storage efficiency, contributes to evolutionary
flexibility and allows for functional fine-tuning in different
cell types or developmental stages of the same organism.
Known since 1977 and honouredwith a Nobel Prize in 1993,
the field received a significant boost from the democratisation
of high-throughput sequencing techniques over the past two.
g Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).decades, allowing for assessing the full extent of transcript
diversity and their correlation with different cell types, states
and diseases [1]. These have notably shown that RNA mis-
splicing underlies a broad number of pathologies [2].
Benzaquen et al. choose the example of the purinergic
P2RX7 receptor to illustrate how alternative splicing could
theoretically influence a large panel of features, such as sub-
cellular localisation, homo- versus heterodimerisation, func-
tion and functionality [3].
P2RX7 recognises extracellular ATP (eATP), and like all
types of nucleotides or nucleosides outside of cells, this is
rather bad news, as it notifies cells of nearby death and danger
due to injury or infection [4].
The main addressees are immune, epithelial and endo-
thelial cells [5], yet all mammalian cells express P2RX7mRNA,
but only a subset displays the functional protein in the cellvier B.V. This is an open access article under the CC BY-NC-ND
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Fig. 1 The diversity of P2RX7 receptor expression and function. P2RX7 expression has been documented in a wide range of
eukaryotic cells, both immune and non-immune. Their localisation, level of activity and downstream effects differ however
among cell types. Cancer cells might overexpress P2RX7 in order to promote proliferation. Source: Benzaquen et al. [3].
b i om e d i c a l j o u r n a l 4 2 ( 2 0 1 9 ) 1 3 7e1 4 0138membrane. The downstream effects of P2RXT activation are
broad, including cell death, proliferation or immune system
activities [Fig. 1].
To start with, the authors recapitulate in a comprehensive
manner the complex molecular ballet of splicing, from the
description of themolecular participants of the “spliceosome”
to the many possibilities to combine different exons, introns,
promoters and polyadenylation sites into an impressive di-
versity of mRNAs.
Subsequently, they discuss the intriguing structural fea-
tures of the P2RX7 protein. The presence of eATP triggers
trimeric receptors to form a channel letting mainly potassium
exit and calcium enter the cell, inducing membrane depolar-
isation. However, the role of many features, such as the long
C-terminal tail or intra-cytoplasmic sequences, is yet unclear.
Following this, Benzaquen et al. hypothesise how themany
splice variants arising from the 13 exons of the human and
mouse P2RX7 gene could tune the amplitude of the eATP-
induced cell response. For example, a heterotrimer made of
the A and B variants seems to have a better plasmamembrane
expression and ion-channel activity compared to the A
version alone, while the association of the A and J forms has a
dominant negative effect over the A-homotrimer. It is thus not
unlikely that the receptor concentration at the plasma mem-
brane, the sensitivity to eATP and the downstream response
are tuned by the respective proportion of different splice
variants. Solid experimental proof still needs to be provided
however, according to the authors.
Moreover, a similar logic would explain how a P2RX7
version unable to trigger cell death but promote proliferationwould be beneficial for cancer cells and fit the observed
overexpression of the receptor in several cancers.
Consequently, the authors conclude their review with a
connection to the thriving field of onco-immunology by
pointing out that tumour-specific splicing products signify the
presence of tumour-specific antigens, which could be targeted
either by a boosted host immune system or laboratory-made
antibodies.Spotlight on original articles
Promising properties of propanolol in breast cancer
treatment
The use of “beta blockers”, antagonists of beta adrenergic re-
ceptors (b-ARs), is commonly associated with the control of
hypertension or abnormal heart rhythms [6]. These G-protein
coupled receptors are bound by adrenaline and noradrenaline,
and mainly stimulate the sympathetic nervous system [7].
However, it turns out that they are also over-expressed by
breast cancer cells [8], which unexpectedly granted beta
blockers a complete new field of potential applications [8].
Propanolol, sold for example as Inderal, is one such medica-
tion and has been in use since 1964 [9]. Nowadays, it is
regarded as one of the safest and most effective medicines
according to the World Health Organisation.
In a previous publication based on a retrospective analysis,
Alexa Montoya et al. had already shown that propanolol
treatment slows down tumour proliferation in early stage
b i om e d i c a l j o u r n a l 4 2 ( 2 0 1 9 ) 1 3 7e1 4 0 139breast cancer patients [10]. In the present publication, the group
assesses the impact of propanolol treatment on cell prolifera-
tion and apoptosis, in parallel on a late stage breast cancer
patient and the MDA-MB-231 breast cancer cell line [11].
Data on the patient's response to the treatment were ob-
tained by comparing the pre-treatment diagnostic biopsywith
tumour tissue from a mastectomy after 25 days of propanolol
treatment. In addition, as to mimic physiological conditions,
the in vitro cell culture experiments were carried out with sub-
lethal but physiologically attainable plasma concentrations of
propanolol.
The authors observe a clear reduction in cancer cell pro-
liferation both in the tumour and the cell culture after prop-
anolol treatment evaluated by Ki-67 staining on the tissues
and flow cytometry cell cycle analysis on the cell line,
corroborated by a reduction in cyclin expression. Further-
more, a significant effect on cell survival is noted, evident by
an increase in p53 protein levels in vivo and in vitro, as well as
the phosphorylation of p53 residues leading to the stabilisa-
tion of the latter. In concordance with this observation, levels
of the pro-survival protein Bcl-2 are decreased in the treated
tissue and cells, strongly hinting that propanolol induces
apoptosis in the cancer cells. An increase of the caspase 3, 6
and 9 cleavage products and the sub-G1 cell cycle population
as well as the presence of phosphatidylserine on the outer cell
surface after treatment of the cell line confirms this
diagnostic.
Propanolol has themajor advantage that it is a well-tested,
non-toxic and inexpensive medication. Having demonstrated
its anti-proliferative and pro-apoptotic effect on both early
and late breast cancer, Montoya et al. plead strongly for a
systematic use of the drug in the framework of breast cancer
treatment in order to potentiate other therapies and for an
investigation if it could also display similar effects on other
cancer types [12].Also in this issue
Original articles
Optimisation of pre-vascularisation for bone tissue engineering
Although bone tissue possesses remarkable inherent repair
and regeneration abilities, the latter can fail after certain
complicated fractures, or because of innate defects. As a
consequence, bone is the second most frequently trans-
planted tissue after blood. Grafting materials traditionally
include bone auto-, allo- or xenografts, or graft substitutes,
each with their advantages and drawbacks. Autografts have
the best osteogenic properties but are limited by donor site
morbidity and availability, allografts bear the risk of rejection,
and xenografts carry the danger of transmission of zoonotic
diseases. In this context, in vitro tissue engineering has
developed as a promising new option for tailor-made bone
grafts over the last decade, with cutting edge tools such as
stem cells and 3D tissue printing [13]. However, the generation
of large grafts poses new problems, for example poor cell
viability in the tissue core due to lacking perfusion. In order
to circumvent this, pre-vascularisation is achieved via theco-culture of endothelial cells with the mesenchymal stem
cells (MSCs) meant for differentiation into bone.
Here, Deegan et al. compare different aggregation tech-
niques and culture conditions of MSCs mixed with 5% human
umbilical vein endothelial cells (HUVECs) in order to deter-
mine their effect on endothelial cell arrangements [14].
The authors find that the best results for endothelial cell
regional arrangements are obtained by suspension culture
aggregates cultured under hydrostatic loading.Moreover, they
show that under these conditions, a low percentage of
HUVECs is sufficient for them to be stimulated into tissue-like
vascular arrangements.
Characteristics of adult necrotising encephalopathy in adults
Acute necrotizing encephalopathy (ANE) is a rare, fulminant
type of encephalopathy, typically preceded by a viral infec-
tion. It initially manifests as multifocal, symmetric, oedema-
tous brain lesions mainly in the thalami, brain stem, cerebral
white matter, and cerebellum, with the oedema gradually
resolving into haemorrhage and necrosis [15]. Given the rarity
of the condition, little is known about any typical inflamma-
tion marker profile associated with ANE. Furthermore, as the
disease is the most common in children under age 5, it is still
unclear if adult ANE cases display the same clinical features as
in paediatric patients. In order to contribute to resolving this
open question, Lin et al. investigate the data of several adult
ANE patients [16]. Their study reveals that adult ANE patients
indeed manifest clinical symptoms, laboratory data, and
neuroimaging findings similar to paediatric cases. However,
adult ANE patients are biased towards females and have
higher mortality and neurological sequelae rates. In addition,
the analysis points towards a role of IL-6 and VCAM-1 in adult
ANE pathogenesis, and a potential role of TGF-b for treatment.
Nuclear magnetic resonance proves its worth in specific
pathogen detection
Fast, cheap, and specific detection of microbial pathogens in
food is of major importance for both the agroalimentary in-
dustry and health services. However, FDA-enforced methods
tend to be culture- or PCR-based, thus time-consuming or
expensive. Seafood, which is often consumed raw or under-
cooked, is a frequent source of pathogens [17]. Vibrio para-
haemolyticus is one example and the causative agent of
gastroenteritis in humans, but recently also of early mortality
syndrome (EMS) in shrimp cultures, causing substantial eco-
nomic loss [18].
Recruiting quantum physics packed into portable bio-
sensors to unmask pathogens has gotten rather popular
recently. Surface-enhanced Raman scattering (SERS) for
example has been used to identify Ebola, Lassa, andmalaria in
a single blood sample in less than half an hour [19]. Nuclear
magnetic resonance spectroscopy (NMR), which relies on the
unique electromagnetic signature of a nanoparticle coupled
either to specific antibodies or primers has been proposed for
the detection of various microorganisms [20,21].
Here, Hash et al. compare a combination of NMR and mo-
lecular biologywith classical real-time PCR for the detection of
V. parahaemolyticus in shrimp [22]. The authors conclude that
the NMR biosensor constitutes a fast, sensitive, and specific
b i om e d i c a l j o u r n a l 4 2 ( 2 0 1 9 ) 1 3 7e1 4 0140detection tool for EMS-causing V. parahaemolyticus that could
be used for diagnostic and quality control.
In situ repair of all-ceramic dental restorations by laser
irradiation
Nowadays, in dental restoration, all-ceramic crowns and
bridges are used instead of metal components, mainly for
aesthetic reasons [23]. Moreover, in order to minimise inter-
vention effort, cost and patient discomfort, the trend in
mending fractures or chippings of these restorations has
recently shifted towards in situ repair using laser surface
treatment [24].
In the present study, Tokar et al. examine the repair bond
strength between composite resin and zirconia/porcelain sur-
faces subjected to various yttrium scandium gallium garnet
(Er,Cr:YSGG) laser pulses [25]. According to the authors, the
application of Er,Cr:YSGG laser pulses increases the repair bond
strength between zirconia and composite resin with a slightly
better result for short pulse rates, despite the controlmethod of
grinding with diamond bur still exhibiting the best results.Conflicts of interest
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